Immunization/Vaccine CPT CODE LIST

All Service Codes for Immunization/Vaccine

• 86615 (CPT) - Antibody; Bordetella
• 86619 (CPT) - Antibody; Borrelia (relapsing fever)
• 86622 (CPT) - Antibody; Brucella
• 86625 (CPT) - Antibody; Campylobacter
• 86628 (CPT) - Antibody; Candida
• 90281 (CPT) - Immune globulin (Ig), human, for intramuscular use
• 90283 (CPT) - Immune globulin (IgIV), human, for intravenous use
• 90284 (CPT) - Immune globulin (SCIg), human, for use in subcutaneous infusions, 100 mg, each
• 90287 (CPT) - Botulinum antitoxin, equine, any route
• 90288 (CPT) - Botulism immune globulin, human, for intravenous use
• 90291 (CPT) - Cytomegalovirus immune globulin (CMV-IgIV), human, for intravenous use
• 90296 (CPT) - Diphtheria antitoxin, equine, any route
• 90371 (CPT) - Hepatitis B immune globulin (HBIg), human, for intramuscular use
• 90375 (CPT) - Rabies immune globulin (RIg), human, for intramuscular and/or subcutaneous use
• 90376 (CPT) - Rabies immune globulin, heat-treated (RIg-HT), human, for intramuscular and/or subcutaneous use
• 90378 (CPT) - Respiratory syncytial virus immune globulin (RSV-IgIM), for intramuscular use, 50 mg, each
• 90379 (CPT) - Respiratory syncytial virus immune globulin (RSV-IgIV), human, for intravenous use
• 90384 (CPT) - Rho(D) immune globulin (RhIg), human, full-dose, for intramuscular use
• 90385 (CPT) - Rho(D) immune globulin (RhIg), human, mini-dose, for intramuscular use
• 90386 (CPT) - Rho(D) immune globulin (RhIgIV), human, for intravenous use
• 90389 (CPT) - Tetanus immune globulin (TIg), human, for intramuscular use
• 90393 (CPT) - Vaccinia immune globulin, human, for intramuscular use
• 90396 (CPT) - Varicella-zoster immune globulin, human, for intramuscular use
• 90465 (CPT) - Immunization administration younger than 8 years of age (includes percutaneous, intradermal, subcutaneous, or intramuscular injections) when the physician counsels the patient/family; first injection (single or combination vaccine/toxoid), per day
• 90466 (CPT) - Immunization administration younger than 8 years of age (includes percutaneous, intradermal, subcutaneous, or intramuscular injections) when the physician counsels the patient/family; each additional injection (single or combination vaccine/toxoid), per day (List separately in addition to code for primary procedure)
• 90467 (CPT) - Immunization administration younger than age 8 years (includes intranasal or oral routes of administration) when the physician counsels the patient/family; first administration (single or combination vaccine/toxoid), per day
• 90468 (CPT) - Immunization administration younger than age 8 years (includes intranasal or oral routes of administration) when the physician counsels the patient/family; each additional administration (single or combination vaccine/toxoid), per day (List separately in addition to code for primary procedure)
• 90471 (CPT) - Immunization administration; one vaccine (single or combination vaccine/toxoid)
• 90472 (CPT) - Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)
• 90473 (CPT) - Immunization administration by intranasal or oral route; one vaccine (single or combination vaccine/toxoid)
• 90474 (CPT) - Immunization administration by intranasal or oral route; each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)
• 90476 (CPT) - Adenovirus vaccine, type 4, live, for oral use
• 90477 (CPT) - Adenovirus vaccine, type 7, live, for oral use
• 90581 (CPT) - Anthrax vaccine, for subcutaneous use
• 90585 (CPT) - Bacillus Calmette-Guerin vaccine (BCG) for tuberculosis, live, for percutaneous use
• 90586 (CPT) - Bacillus Calmette-Guerin vaccine (BCG) for bladder cancer, live, for intravesical use
• 90632 (CPT) - Hepatitis A vaccine, adult dosage, for intramuscular use
• 90633 (CPT) - Hepatitis A vaccine, pediatric/adolescent dosage-2 dose schedule, for intramuscular use
• 90634 (CPT) - Hepatitis A vaccine, pediatric/adolescent dosage-3 dose schedule, for intramuscular use
• 90636 (CPT) - Hepatitis A and hepatitis B vaccine (HepA-HepB), adult dosage, for intramuscular use
• 90645 (CPT) - Hemophilus influenza b vaccine (Hib), HbOC conjugate (4 dose schedule), for intramuscular use
• 90646 (CPT) - Hemophilus influenza b vaccine (Hib), PRP-D conjugate, for booster use only, intramuscular use
• 90647 (CPT) - Hemophilus influenza b vaccine (Hib), PRP-OMP conjugate (3 dose schedule), for intramuscular use
• 90648 (CPT) - Hemophilus influenza b vaccine (Hib), PRP-T conjugate (4 dose schedule), for intramuscular use
• 90649 (CPT) - Human Papilloma virus (HPV) vaccine, types 6, 11, 16, 18 (quadrivalent), 3 dose schedule, for intramuscular use
• 90655 (CPT) - Influenza virus vaccine, split virus, preservative free, when administered to children 6-35 months of age, for intramuscular use
• 90656 (CPT) - Influenza virus vaccine, split virus, preservative free, when administered to individuals 3 years and older, for intramuscular use
• 90657 (CPT) - Influenza virus vaccine, split virus, when administered to children 6-35 months of age, for intramuscular use
• 90658 (CPT) - Influenza virus vaccine, for 3 years of age and older, intramuscular use
• 90660 (CPT) - Influenza virus vaccine, live, for intranasal use
• 90661 (CPT) - Influenza virus vaccine, derived from cell cultures, subunit, preservative and antibiotic free, for intramuscular use
• 90662 (CPT) - Influenza virus vaccine, split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use
• 90663 (CPT) - Influenza virus vaccine, pandemic formulation
• 90665 (CPT) - Lyme disease vaccine, adult dosage, for intramuscular use
• 90669 (CPT) - Pneumococcal conjugate vaccine, polyvalent, when administered to children younger than 5 years, for intramuscular use
• 90675 (CPT) - Rabies vaccine, for intramuscular use
• 90676 (CPT) - Rabies vaccine, for intradermal use
• 90680 (CPT) - Rotavirus vaccine, pentavalent, 3 dose schedule, live, for oral use
• 90690 (CPT) - Typhoid vaccine, live, oral
• 90691 (CPT) - Typhoid vaccine, Vi capsular polysaccharide (ViCPs), for intramuscular use
• 90692 (CPT) - Typhoid vaccine, heat- and phenol-inactivated (H-P), for subcutaneous or intradermal use
• 90693 (CPT) - Typhoid vaccine, acetone-killed, dried (AKD), for subcutaneous use (U.S. military)
• 90698 (CPT) - Diphtheria, tetanus toxoids, acellular pertussis vaccine, haemophilus influenza Type B, and poliovirus vaccine, inactivated (DTaP - Hib - IPV), for intramuscular use
• 90700 (CPT) - Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), when administered to individuals younger than 7 years, for intramuscular use
• 90701 (CPT) - Diphtheria, tetanus toxoids, and whole cell pertussis vaccine (DTP), for intramuscular use
• 90702 (CPT) - Diphtheria and tetanus toxoids (DT) adsorbed when administered to individuals younger than 7 years, for intramuscular use
• 90703 (CPT) - Tetanus toxoid adsorbed, for intramuscular use
• 90704 (CPT) - Mumps virus vaccine, live, for subcutaneous use
• 90705 (CPT) - Measles virus vaccine, live, for subcutaneous use
• 90706 (CPT) - Rubella virus vaccine, live, for subcutaneous use
• 90707 (CPT) - Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use
• 90708 (CPT) - Measles and rubella virus vaccine, live, for subcutaneous use
• 90710 (CPT) - Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use
• 90712 (CPT) - Poliovirus vaccine, (any type[s]) (OPV), live, for oral use
• 90713 (CPT) - Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use
• 90714 (CPT) - Tetanus and diphtheria toxoids (Td) adsorbed, preservative free, when administered to individuals 7 years or older, for intramuscular use
• 90715 (CPT) - Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use
• 90716 (CPT) - Varicella virus vaccine, live, for subcutaneous use
• 90717 (CPT) - Yellow fever vaccine, live, for subcutaneous use
• 90718 (CPT) - Tetanus and diphtheria toxoids (Td) adsorbed when administered to individuals 7 years or older, for intramuscular use
• 90719 (CPT) - Diphtheria toxoid, for intramuscular use
• 90720 (CPT) - Diphtheria, tetanus toxoids, and whole cell pertussis vaccine and Hemophilus influenza B vaccine (DTP-Hib), for intramuscular use
• 90721 (CPT) - Diphtheria, tetanus toxoids, and acellular pertussis vaccine and Hemophilus influenza B vaccine (DtaP-Hib), for intramuscular use
• 90723 (CPT) - Diphtheria, tetanus toxoids, acellular pertussis vaccine, Hepatitis B, and poliovirus vaccine, inactivated (DtaP-HepB-IPV), for intramuscular use
• 90725 (CPT) - Cholera vaccine for injectable use
• 90727 (CPT) - Plague vaccine, for intramuscular use
• 90732 (CPT) - Pneumococcal polysaccharide vaccine (PPV23), adult dose
• 90733 (CPT) - Meningococcal polysaccharide vaccine (any group(s)), for subcutaneous use
• 90734 (CPT) - Meningococcal conjugate vaccine, serogroups A, C, Y and W-135 (tetravalent), for intramuscular use
• 90735 (CPT) - Japanese encephalitis virus vaccine, for subcutaneous use
• 90736 (CPT) - Zoster (shingles) vaccine, live, for subcutaneous injection
• 90740 (CPT) - Hepatitis B vaccine, dialysis or immunosuppressed patient dosage (3 dose schedule), for intramuscular use
• 90743 (CPT) - Hepatitis B vaccine, adolescent (2 dose schedule), for intramuscular use
• 90744 (CPT) - Hepatitis B vaccine, pediatric/adolescent dosage (3 dose schedule), for intramuscular use
• 90746 (CPT) - Hepatitis B vaccine, adult dosage, for intramuscular use
• 90747 (CPT) - Hepatitis B vaccine, dialysis or immunosuppressed patient dosage
• 90748 (CPT) - Hepatitis B and Hemophilus influenza b vaccine (HepB-Hib), for intramuscular use
• 90749 (CPT) - Unlisted vaccine/toxoid
• G0008 (CPT) - Flu Vaccine
• G0009 (CPT) - Pneumonia Vaccine
• G0010 (CPT) - Hepatitis Vaccine
• S0195 (CPT) - PNEUMOCOCCAL CONJUGATE VACCINE, POLYVALENT, INTRAMUSCULAR, FOR CHILDREN FROM; FIVE YEARS TO NINE YEARS OF AGE WHO HAVE NOT PREVIOUSLY RECEIVED THE VACCINE